Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 3017108, 13 pages
http://dx.doi.org/10.1155/2016/3017108
Research Article

Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in MCF-7 Breast Cancer Cells

1Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
2Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo 11796, Egypt

Received 3 September 2015; Accepted 27 October 2015

Academic Editor: Mohamed A. Dkhil

Copyright © 2016 Tarek K. Motawi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Goldhirsch, J. N. Ingle, R. D. Gelber, A. S. Coates, B. Thürlimann, and H.-J. Senn, “Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer,” Annals of Oncology, vol. 20, no. 8, pp. 1319–1329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Higgins and J. Baselga, “Targeted therapies for breast cancer,” The Journal of Clinical Investigation, vol. 121, no. 10, pp. 3797–3803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Lagadec, E. Adriaenssens, R. A. Toillon et al., “Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells,” Oncogene, vol. 27, no. 10, pp. 1472–1477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Orsolic, S. Terzic, Z. Mihaljevic, L. Sver, and I. Basic, “Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth,” Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp. 1928–1933, 2005. View at Publisher · View at Google Scholar
  6. X. Wang, J. Pang, J. A. Maffucci et al., “Pharmacokinetics of caffeic acid phenethyl ester and its catecholring fluorinated derivative following intravenous administration to rats,” Biopharmaceutics and Drug Disposition, vol. 30, no. 5, pp. 221–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Son and B. A. Lewis, “Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship,” Journal of Agricultural and Food Chemistry, vol. 50, no. 3, pp. 468–472, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kimura, H. Okuda, T. Okuda, T. Hatano, I. Agata, and S. Arichi, “Studies on the activities of tannins and related compounds from medicinal plants and drugs. VII. Effects of extracts of leaves of Artemisia species, and caffeic acid and chlorogenic acid on lipid metabolic injury in rats fed peroxidized oil,” Chemical and Pharmaceutical Bulletin, vol. 33, no. 5, pp. 2028–2034, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Laranjinha, O. Vieira, V. Madeira, and L. Almeida, “Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration,” Archives of Biochemistry and Biophysics, vol. 323, no. 2, pp. 373–381, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Motomura, K. M. Kwon, S.-J. Suh et al., “Propolis induces cell cycle arrest and apoptosis in human leukemic U937 cells through Bcl-2/Bax regulation,” Environmental Toxicology and Pharmacology, vol. 26, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Xiang, D. Wang, Y. He et al., “Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the β-catenin/T-cell factor signaling,” Anti-Cancer Drugs, vol. 17, no. 7, pp. 753–762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M.-F. Chen, C.-T. Wu, Y.-J. Chen, P. C. Keng, and W.-C. Chen, “Cell killing and radio sensitization by Caffeic Acid Phenethyl Ester (CAPE) in lung cancer cells,” Journal of Radiation Research, vol. 45, no. 2, pp. 253–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-J. Chen, W.-H. Chang, C.-C. Lin et al., “Caffeic acid phenethyl ester induces apoptosis of human pancreatic cancer cells involving caspase and mitochondrial dysfunction,” Pancreatology, vol. 8, no. 6, pp. 566–576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Wu, C. Omene, J. Karkoszka et al., “Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer,” Cancer Letters, vol. 308, no. 1, pp. 43–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. A. Peralta, M. L. Viegas, S. Louis, D. L. Engle, and G. L. Dunnington, “Effect of vitamin E on tamoxifen-treated breast cancer cells,” Surgery, vol. 140, no. 4, pp. 607–615, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Sartippour, R. Pietras, D. C. Marquez-Garban et al., “The combination of green tea and tamoxifen is effective against breast cancer,” Carcinogenesis, vol. 27, no. 12, pp. 2424–2433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. T.-C. Chou, “Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies,” Pharmacological Reviews, vol. 58, no. 3, pp. 621–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Fernandes-Alnemri, G. Litwack, and E. S. Alnemri, “CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme,” The Journal of Biological Chemistry, vol. 269, no. 49, pp. 30761–30764, 1994. View at Google Scholar · View at Scopus
  21. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Griess, “Bemerkungen zu der abhandlung der HH. Weselsky und benedikt ‘Ueber einige Azoverbindungen’,” Berichte der Deutschen Chemischen Gesellschaft, vol. 12, no. 1, pp. 426–428, 1879. View at Publisher · View at Google Scholar
  24. C. K. Osborne, D. H. Boldt, G. M. Clark, and J. M. Trent, “Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase,” Cancer Research, vol. 43, no. 8, pp. 3583–3585, 1983. View at Google Scholar · View at Scopus
  25. S. Gao and J. Singh, “In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes,” Journal of Controlled Release, vol. 51, no. 2-3, pp. 193–199, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. D. P. De Santana, R. M. C. Braga, R. Strattmman et al., “Reversed phase HPLC determination of tamoxifen in dog plasma and its pharmacokinetics after a single oral dose administration,” Quimica Nova, vol. 31, no. 1, pp. 47–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Belizário, I. Alves, J. M. Occhiucci, M. Garay-Malpartida, and A. Sesso, “A mechanistic view of mitochondrial death decision pores,” Brazilian Journal of Medical and Biological Research, vol. 40, no. 8, pp. 1011–1024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Mandlekar and A.-N. T. Kong, “Mechanisms of tamoxifen-induced apoptosis,” Apoptosis, vol. 6, no. 6, pp. 469–477, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Watabe, K. Hishikawa, A. Takayanagi, N. Shimizu, and T. Nakaki, “Caffeic acid phenethyl ester induces apoptosis by inhibition of NF kappa B and activation of Fas in human breast cancer MCF-7 cells,” The Journal of Biological Chemistry, vol. 279, no. 7, pp. 6017–6026, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Nagata, “Apoptotic DNA fragmentation,” Experimental Cell Research, vol. 256, no. 1, pp. 12–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Cao and D. J. Klionsky, “Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein,” Cell Research, vol. 17, no. 10, pp. 839–849, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. K. W. Yip and J. C. Reed, “Bcl-2 family proteins and cancer,” Oncogene, vol. 27, no. 50, pp. 6398–6406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Pattingre, A. Tassa, X. Qu et al., “Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy,” Cell, vol. 122, no. 6, pp. 927–939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Wirawan, L. Vande Walle, K. Kersse et al., “Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria,” Cell Death and Disease, vol. 1, no. 1, article e18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Qadir, B. Kwok, W. H. Dragowska et al., “Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization,” Breast Cancer Research and Treatment, vol. 112, no. 3, pp. 389–403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. J. Hwang, H. N. Kim, J. Kim et al., “Zinc (II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line,” Biometals, vol. 23, no. 6, pp. 997–1013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Vijayakurup, C. Spatafora, C. Tringali, P. C. Jayakrishnan, P. Srinivas, and S. Gopala, “Phenethyl caffeate benzoxanthene lignan is a derivative of caffeic acid phenethyl ester that induces bystander autophagy in WiDr cells,” Molecular Biology Reports, vol. 41, no. 1, pp. 85–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Poillet-Perez, G. Despouy, R. Delage-Mourroux, and M. Boyer-Guittaut, “Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy,” Redox Biology, vol. 4, pp. 184–192, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. U. Coskun, N. Gunel, B. Sancak, E. Onuk, M. Bayram, and A. Cihan, “Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients,” Clinical & Experimental Immunology, vol. 137, no. 3, pp. 546–551, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. El-Refaei and M. M. El-Naa, “Inhibitory effect of caffeic acid phenethyl ester on mice bearing tumor involving angiostatic and apoptotic activities,” Chemico-Biological Interactions, vol. 186, no. 2, pp. 152–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Huang, C. A. Pettaway, H. Uehara, C. D. Bucana, and I. J. Fidler, “Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis,” Oncogene, vol. 20, no. 31, pp. 4188–4197, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Loo, L. A. Lesoon-Wood, and R. V. Cooney, “Effects of tamoxifen on nitric oxide synthesis and neoplastic transformation in C3H 10T1/2 fibroblasts,” Cancer Letters, vol. 122, no. 1-2, pp. 67–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. P. I. Moreira, J. B. Custódio, C. R. Oliveira, and M. S. Santos, “Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen,” Neuropharmacology, vol. 48, no. 3, pp. 435–447, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. S. Singhal, S. Awasthi, U. Pandya et al., “The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells,” Toxicology Letters, vol. 109, no. 1-2, pp. 87–95, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Riganti, E. Miraglia, D. Viarisio et al., “Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux,” Cancer Research, vol. 65, no. 2, pp. 516–525, 2005. View at Google Scholar · View at Scopus
  46. L. J. Ignarro, G. M. Buga, L. H. Wei, P. M. Bauer, G. Wu, and P. Del Soldato, “Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4202–4208, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lepoivre, F. Fieschi, J. Coves, L. Thelander, and M. Fontecave, “Inactivation of ribonucleotide reductase by nitric oxide,” Biochemical and Biophysical Research Communications, vol. 179, no. 1, pp. 442–448, 1991. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-C. Drapier and J. B. Hibbs Jr., “Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible,” Journal of Clinical Investigation, vol. 78, no. 3, pp. 790–797, 1986. View at Publisher · View at Google Scholar · View at Scopus
  49. J.-C. Drapier and J. B. Hibbs Jr., “Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochrondrial iron-sulfur enzymes in the macrophage effector cells,” Journal of Immunology, vol. 140, no. 8, pp. 2829–2838, 1988. View at Google Scholar · View at Scopus
  50. R. N. Watts, C. Hawkins, P. Ponka, and D. R. Richardson, “Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7670–7675, 2006. View at Publisher · View at Google Scholar · View at Scopus